Postcovid syndrome: regarding the risks of developing thrombotic complications in patients with ischemic limb lesions (clinical cases)

Authors

DOI:

https://doi.org/10.26641/2307-0404.2021.3.242332

Keywords:

сovid-19, endotheliocytes, thrombotic complications, thrombovasculitis

Abstract

The problem of postcovidal syndrome is currently relevant, since in the stabilization of vital functions, the processes of immunological inflammation with significant disorders of endothelium functions continue; this causes tissue ischemization, especially in the presence of changes at the level of microcirculation in patients with angiopathy and vasculopathy. It is noted that in COVID-19 comorbidity with hypertension, coronary heart disease, diabetes mellitus, systemic connective tissue diseases the risks, course, prognosis and development of vascular complications significantly increase. The severity of the inflammatory process and predicting the likelihood of complications is accompanied by changes in laboratory indicators, namely: in the general blood test – leukocytosis, an increase in the level of neitrophilic granulocytes, a decrease in the content of hemoglobin and platelets; in biochemical indicators – a decrease in the level of the general protein, an increase in the indicators of alaninetransferase, aspartaminotransferase, C-reactive protein, lactatdehydrogenase, ferritin; coagulation changes – increase in the level of fibrinogen, D-dimer, reduction of activated partial thromboplastic time. On the basis of the considered clinical cases, taking into account modern ideas about the peculiarities of the development of thrombotic complications in COVID-19 infection in patients with ischemic lesions of the extremities, the need to prescribe low molecular weight heparin  as a selection drug for the treatment of thrombophilic conditions has been proven. Detailed study of histological material is important for establishing changes at the level of microcirculation and ischemization of tissues, this will allow to develop algorithms for the treatment and prevention of complications. Solving these issues, not only in the presence of COVID-19, but also in any stressful cases, requires careful clarification of the mechanisms for the development of complications and a timely adequate integrated approach to treatment to improve and stabilize the condition of patients.

References

Galstyan GM. [Coagulopathy in COVID-19]. Pulmonologiya. 2020;30(5):645-57. Russian. doi: https://doi.org/10.18093/0869-0189-2020-30-5-645-657

Chebotareva NV, Berns AS, Lebedeva MV, Moiseev SV. [Clinical impact of plasma haemostasis disorders and their correction in chronic glomerulonephritis with nephrotic syndrome]. Gematologiya i transfuziologiya. 2020;65(4):473-82. Russian. doi: https://doi.org/10.35754/0234-5730-2020-65-4-473-482

Zhang B, Zhou X, Qiu Y, Song Y, Feng F, Feng J, et al. Clinical characteristics of 82 cases of death from COVID-19. PLoS ONE. 2020;15(7):e0235458. doi: https://doi.org/10.1371/journal.pone.0235458

Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708-20. doi: https://doi.org/10.1056/NEJMoa2002032

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. doi: https://doi.org/10.1016/S0140-6736(20)30183-5

Levi M, Thachil J, Iba T, et al. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun;7(6):438-40. doi: https://doi.org/10.1016/S2352-3026(20)30145-9

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. doi: https://doi.org/10.1016/S0140-6736(20)30211-7

Delcroix M, Torbicki A, Gopalan D, et al. ERS Statement on Chronic Thromboembolic Pulmonary Hypertension. European Respiratory Journal. 2020. doi: https://doi.org/10.1183/13993003.02828-2020

Strangfeld A, Schäfer M, Gianfrancesco MA, et al. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals of the Rheumatic Diseases. Published Online First: 27 January 2021. 2021;0:1-13. doi: http://dx.doi.org/10.1136/annrheumdis-2020-219498

Ashour HM, Elkhatib WF, Rahman M, et al. Insights into the recent 2019 novel coronavirus SARS-CoV-2 in light of past human coronavirus outbreaks. Pathogens. 2020;9(3):1-15. DOI: https://doi.org/10.3390/pathogens9030186

Iba T, Miki T, Hashiguchi N, et al. Is the neutrophil a “prima donna” in the procoagulant process during sepsis? Crit. Care. 2014;18(4):230. doi: https://doi.org/10.1186/cc13983

Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J. Thromb. Haemost. 2020;18(5):1023-6. doi: https://doi.org/10.1111/jth.14810

Marongiu F, Grandone E, Barcellona D. Pulmonary thrombosis in 2019-nCoV pneumonia? J. Tromb. Haemost. 2020;18(6):1511-13. doi: https://doi.org/10.1111/jth.14818

New COVID-19 HOPE clinical trial recommendations introduced today may reduce or eliminate mechanical ventilation for coronavirus patients. Bio¬Space. 2020 Mar 30.

URL: https://www.biospace.com/article/releases/new-covid-19-hope-clinical-trial-recommendations-introduced-today-may-reduce-or-eliminate-mechanical-ventilation-for-coronaviruspatients/?keywords=new¬+covid+19+hope+clinicаl+trial+recommendations+introduced+today+may+reduce+or+eliminate+mechanical+ventilation+for+coronavirus+patients

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Internal Medicine. 2020;180(7):934. doi: https://doi.org/10.1001/jamainternmed.2020.0994

Published

2021-09-30

How to Cite

1.
Vysochyna I, Nikolaenko-Kamyshova T, Biesiedin O. Postcovid syndrome: regarding the risks of developing thrombotic complications in patients with ischemic limb lesions (clinical cases). Med. perspekt. [Internet]. 2021Sep.30 [cited 2024Nov.20];26(3):205-11. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/242332

Issue

Section

A CASE FROM PRACTICE